Published dosing context mainly involves topical clinical-study use, diabetic-ulcer wound studies, and newer registered topical wound-healing trials, not an FDA-approved injectable label [3], 7
This product has no artificial additives, including sweeteners
doi: 10.1002/14651858.CD003373
Reconstitution with bacteriostatic water or an appropriate laboratory solvent is required prior to research use
Yes, Medicaid covers this code in most states when the injection is medically necessary
This is an interesting proposition since a previous study demonstrated that skin ER abundance is not altered by menopause, while dermal ER expression declined by 15% after menopause, 110 suggesting a decline in estrogen hormone action